523 related articles for article (PubMed ID: 21619430)
21. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
23. The contribution of pharmacogenetics to pharmacovigilance.
Bondon-Guitton E; Despas F; Becquemont L
Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
[TBL] [Abstract][Full Text] [Related]
24. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
Momper JD; Wagner JA
Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
27. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
[TBL] [Abstract][Full Text] [Related]
28. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
Carrillo Norte JA
Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
Lee SY; McLeod HL
J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics in children.
Rieder M
Methods Mol Biol; 2014; 1175():687-707. PubMed ID: 25150881
[TBL] [Abstract][Full Text] [Related]
31. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
33. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.
Mhandire DZ; Goey AKL
Mol Diagn Ther; 2022 Mar; 26(2):137-151. PubMed ID: 35113367
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
35. Translation of pharmacogenetic knowledge into cancer therapeutics.
Yong WP; Innocenti F
Clin Adv Hematol Oncol; 2007 Sep; 5(9):698-706. PubMed ID: 17982411
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
Cheng CM; So TW; Bubp JL
Ann Pharmacother; 2021 Oct; 55(10):1185-1194. PubMed ID: 33384014
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling.
Schuck RN; Grillo JA
AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182
[TBL] [Abstract][Full Text] [Related]
38. Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.
Piana C; Surh L; Furst-Recktenwald S; Iolascon A; Jacqz-Aigrain EM; Jonker I; Russo R; van Schaik RH; Wessels J; Della Pasqua OE
J Clin Pharmacol; 2012 May; 52(5):704-16. PubMed ID: 21566202
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenomic data for personalized medicines].
Yamazaki H
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1886-90. PubMed ID: 16282721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
